Peter V. Robinson

Enable Biosciences (United States)

Papers

1

Total Citations

32

H-Index

1

About

Peter V. Robinson is a leading figure in the development of high-throughput diagnostic technologies, with a primary focus on serological assays and infectious disease detection. His most impactful work centers on the rapid, sensitive, and specific detection of antibodies, particularly in response to emerging viral threats. Robinson's landmark 2020 study, which has garnered 32 citations, introduced a fully automated liquid-handling robotic system for detecting SARS-CoV-2 antibodies. This work addressed a critical global need during the COVID-19 pandemic, enabling large-scale community screening and accurate assessment of infection prevalence. By automating the serological testing process, Robinson's innovation significantly improved both throughput and reliability, aiding in the identification of infected patients and supporting epidemiological studies. His contributions exemplify the intersection of robotics, immunology, and public health, providing scalable solutions for pandemic response. Robinson's research continues to influence the design of automated diagnostic platforms, making him a key contributor to the advancement of high-throughput serology and its application in global health crises.

Research Focus

Key Achievements

1
H-Index
1
Papers
32
Total Citations
32
Avg Citations/Paper
🏆 Most Cited Paper
Sensitive and Specific Detection of SARS-CoV-2 Antibodies Using a High-Throughput, Fully Automated Liquid-Handling Robotic System
32 citations · 2020
📈 Most Prolific Year: 2020 (1 Papers)
🤝 Key Collaborators: 9
🏛 Institutions: Enable Biosciences (United States)

Top Papers

  1. 1

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 4 days ago